[EN] SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS<br/>[FR] DÉRIVÉS SUBSTITUÉS D'ARYLES ET D'HÉTÉROARYLES FUSIONNÉS AU TITRE D'INHIBITEURS DE PI3K
申请人:INCYTE CORP
公开号:WO2011075630A1
公开(公告)日:2011-06-23
The present invention provides fused aryl and heteroaryl derivatives of Formula I that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
申请人:F. HOFFMANN-LA ROCHE LTD
公开号:US20160297763A1
公开(公告)日:2016-10-13
The present invention relates to a compound having the general formula I, optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof,
which is useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.